MULTI REVERSE CONVERTIBLE - VODAFONE GROUP/ROCHE GS Share Price

Certificat

ZBLLTQ

CH1314028130

Real-time Bid/Ask 09:02:43 29/05/2024 BST
97.74 GBX / 98.54 GBX -0.21% Intraday chart for MULTI REVERSE CONVERTIBLE - VODAFONE GROUP/ROCHE GS
Current month+4.73%
1 month+3.83%
Date Price Change
27/05/24 98.35 -0.09%
24/05/24 98.44 -0.54%
23/05/24 98.97 -0.02%
22/05/24 98.99 -0.72%

Delayed Quote Swiss Exchange

Last update May 27, 2024 at 04:20 pm

More quotes

Static data

Product typeReverse Convertibles
Buy / SellCALL
Underlying ROCHE HOLDING AG
Issuer LEONTEQ
ZBLLTQ
ISINCH1314028130
Date issued 24/01/2024
Strike 243.6 CHF
Maturity 24/01/2025 (241 Days)
Parity 0.24 : 1
Emission price 100 p
Emission volume N/A
Settlement both
Currency GBX

Technical Indicators

Highest since issue 100.2 p
Lowest since issue 92.95 p
Spread 8 p
Spread %0.81%

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
228.8 CHF
Average target price
279.8 CHF
Spread / Average Target
+22.30%
Consensus
  1. Stock Market
  2. Certificates
  3. ZBLLTQ Certificat